Abstract:Objectives: Chronic rejection remains the leading cause of progressive decline in graft function. Accumulating evidence indicates that macrophages participate in chronic rejection dependent on CD40-CD40L. The FOS family members are critical in inflammatory and immune responses. However, the mechanisms underlying the role of FOS family members in chronic rejection remain unclear. In this study, we aimed to elucidate the role and underlying mechanisms of FOS-positive macrophages regulated by CD40 that mediate chronic allograft rejection. Materials and methods: We downloaded publicly accessible chronic rejection kidney transplant single-cell sequencing datasets from the gene expression omnibus database. Differentially expressed genes between the CD40hi and CD40low macrophage chronic rejection groups were analyzed. We established a chronic rejection mouse model by using CTLA-4-Ig. We treated bone marrow-derived macrophages with an anti-CD40 antibody. We assessed expression of the FOS family by flow cytometry, real-time quantitative polymerase chain reaction, Western blotting, and immunofluorescence. We identified altered signaling pathways by using RNA sequencing analysis. We detected DNA specifically bound to transcription factors by using ChIP-sequencing, with detection of the degree of graft fibrosis and survival. Results: FOS was highly expressed on CD40hi macrophages in patients with chronic transplantrejection. Mechanistically, we showed that CD40 activated NF-κB2 translocation into the nucleus to upregulate c-Fos and FosB expression, thus promoting chronic rejection of cardiac transplant.We showed thatNF-κB2 regulated c-Fos and FosB expression by binding to the c-fos and fosb promoter regions. Inhibition of c-Fos/activator protein-1 decreased graft fibrosis and prolonged graft survival. Conclusions: CD40 may activate transcription factor NF-κB2 translocation into the nucleus of macrophages to upregulate c-Fos and FosB expression, thus promoting chronic rejection of cardiac transplant. Inhibition of c-Fos/activator protein-1 decreased grafts fibrosis and prolonged graft survival.

Unlocking Macrophage Secrets: Histone Deacetylases in Chronic Transplant Rejection

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs.

Targeting Macrophages in Organ Transplantation: A Step Toward Personalized Medicine

HDAC Inhibitors: Novel Immunosuppressants for Allo‐ and Xeno‐ Transplantation

The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection

FOS+ Macrophages Promote Chronic Rejection of Cardiac Transplantation

Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.

HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation

The Evolving Roles of Macrophages in Organ Transplantation

Intragraft immune cells: accomplices or antagonists of recipient-derived macrophages in allograft fibrosis?

Cytokines and adhesion molecules in chronic rejection

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

Dysregulated Treg repair responses lead to chronic rejection after heart transplantation

Chronic Rejection After Kidney Transplantation

The Contribution of the Monocyte-Macrophage Lineage to Immunotherapy Outcomes

The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation

Transcriptomics-based identification of TYROBP and TLR8 as novel macrophage-related biomarkers for the diagnosis of acute rejection after kidney transplantation

Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation

Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections

Hypoxia inducible factor 2α promotes tolerogenic macrophage development during cardiac transplantation through transcriptional regulation of colony stimulating factor 1 receptor